Iodide

Iodide

SCHEMBL5145376

CCO[n+]1ccc(C(=O)OC)cc1.[I-]

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.47
ALDH1A1 P00352 2/20 0.46
MAPT P10636 3/20 0.46
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
CA12 O43570 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
CA14 Q9ULX7 1/20 0.46
LOXL2 Q9Y4K0 1/20 0.44
HPGD P15428 1/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
HTT P42858 1/20 0.42
CYP4A11 Q02928 2/20 0.41
LMNA P02545 1/20 0.40
CYP4F2 P78329 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10169860 0.84 CA1 (0.56) TSHRALDH1A1MAPTCA1CA2
SCHEMBL12039194 0.79 ALDH1A1 (0.50) TSHRALDH1A1MAPTCA1CA2
SCHEMBL12039213 0.79 ALDH1A1 (0.44) TSHRALDH1A1MAPTCA1CA2
SCHEMBL12039249 0.79 CA12 (0.42) TSHRALDH1A1CA1CA2TDP1
SCHEMBL12039177 0.79 CA1 (0.57) TSHRALDH1A1MAPTCA1CA2
Iodide SCHEMBL4873050 0.78 ALDH1A1 (0.57) TSHRALDH1A1MAPTCA1CA2
SCHEMBL12039207 0.77 PARP10 (0.49) ALDH1A1MAPTTDP1HPGDMEN1
SCHEMBL5681926 0.76 ALDH1A1 (0.58) TSHRALDH1A1MAPTCA1CA2
Iodide SCHEMBL3568331 0.75 TSHR (0.56) TSHRALDH1A1MAPTCA1CA2
SCHEMBL12039173 0.74 ALDH1A1 (0.60) TSHRALDH1A1MAPTLMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7273953-B2 Process for producing arylamine FUJIFILM FINECHEMICALS CO., LTD. (JP) 2007-09-25 US disclosed
US-20060069287-A1 Process for producing arylamine FUJIFILM FINECHEMICALS CO., LTD. (JP) 2006-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060069287-A1 Process for producing arylamine TYR, AADAC, AOC2 TSHR 605/4885ALDH1A1 747/4885MAPT 2610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.